axlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusseaxlr_logo-2022_HD_bleudeprusse

  • SATT AxLR
    • SATT AxLR
    • Governance
    • Services for companies
    • Annual reports
  • Assisting you
    • Researchers
      • Call-for-projects
    • Companies
    • Startups
    • Practical guide
  • Technology offerings
    • Invest
      • In our technologies
      • In our startups
    • Technologies
    • Startups
    • AxLR TV
  • Working with AxLR
    • Purchasing & public procurement
    • Join us
    • Our startups are hiring
  • Media
    • News
    • Agenda
    • Press kit
    • Communication kit
  • Contact
English
✕
  • Home
  • TELE-MOUV
AUTOMATIC VARROA COUNTER
30 July 2019
AVIITAM
6 May 2019

TELE-MOUV

TELE-MOUV

Development of a medically validated remote rehabilitation solution to improve the prevention and handling of chronic diseases

Marketed technology

Technology marketed by a partner

IP

  • N/A

Establishment(s)

  • University of Montpellier
  • Montpellier CHU
  • Inserm

Laboratory(ies)

  • Physiology and Experimental Heart and Muscle Medicine

Keywords

  • Telemedicine
  • Chronic diseases

Co-financed by

Context

Chronic diseases are the primary cause of premature mortality, morbidity, and disability in developed countries, making them the leading expense in terms of health care and thus representing a significant public health problem. Chronic diseases share many common risk factors, namely environmental and behavioral considerations related to people’s lifestyle. For example, nearly one billion people are overweight today. The benefits of rehabilitation have been established scientifically for many chronic diseases, notably based on TNMs and on physical activity, changes in dietary habits, and therapeutic education.

Benefits

Tele-Mouv’s remote rehabilitation solution will give patients who suffer from chronic diseases access to various rehabilitation resources, and help maintain results over the long-term. The solution will favor patients’ self-management of their disease, enabling them to practice activities at home or near their living space. A dematerialized version of this solution will be available in SaaS mode, with two versions offered as kits: a telehealth version and a telemedicine version.

Applications

Telehealth, telemedicine, chronic diseases, obesity, type 2 diabetes, chronic obstructive pulmonary disease, sleep apnea syndrome.

MARKETED TECHNOLOGY I Chronic diseases – Telemedicine

Share
3

Related posts

8 September 2021

StabCFTR


En savoir +
6 July 2021

HTLV-1


En savoir +
30 June 2021

REEFPULSE


En savoir +
© 2023, AxLR - SATT Occitanie Méditerranée. All rights reserved. | Legal terms & Privacy policy
English
  • No translations available for this page